New Horizons in Venous Thromboembolism Management: A Narrative Review
Journal of Clinical Medicine · 29.10.2025 · 14 (21) · 7668
DOI: 10.3390/jcm14217668 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 29.10.2025. Verfasst von Wassim Bedrouni und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Venous thromboembolism (VTE) remains a major cause of cardiovascular morbidity and mortality worldwide, and is a staple of daily clinical practice. While we have seen significant advancements in therapeutics over the last 20 years, several questions and controversies remain in the selection and duration of available therapies, as well as balancing the consequences of VTE and the bleeding risk imposed by treatment modalities. In recent years, new evidence based on randomized trials and registries have reshaped the therapeutic landscape. This narrative review synthesizes the latest advancements and future directions in VTE care, including recent guideline updates, new evidence pertaining to established pharmacologic therapy, risk stratification, interventional and procedural options, and special populations including the management of cancer-associated thrombosis, and the emerging promise of factor XI inhibition. In diagnostics, the field is moving beyond traditional methods with the investigation of novel biomarkers from proteomic and metabolomic studies and the clinical implementation of advanced imaging modalities like photon-counting CT, which offers superior resolution at lower radiation doses. Artificial intelligence is emerging as a transformative tool, potentially enhancing diagnostic accuracy in imaging. Ultimately, this review will assist clinicians in integrating evolving evidence with patient-centered decision-making to maximize benefit while minimizing harm and treating the diverse and common clinical problems of VTE.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada.
- Department of Medicine, McGill University, Montreal, PQ H3A 3H3, Canada.
- St. Joseph's Healthcare Hamilton, Room F-544, 50 Charlton Ave East, Hamilton, ON L8N 4A6, Canada.
Zitieren
APA
Bedrouni, W., Bedrouni, M., & Douketis, J. (2025). New Horizons in Venous Thromboembolism Management: A Narrative Review. Journal of Clinical Medicine, 14(21), 7668. https://doi.org/10.3390/jcm14217668
Vancouver
Bedrouni W, Bedrouni M, Douketis J. New Horizons in Venous Thromboembolism Management: A Narrative Review. Journal of Clinical Medicine. 2025;14(21):7668. doi:10.3390/jcm14217668
BibTeX
@article{Bedrouni2025,
author = {Bedrouni, Wassim and Bedrouni, Mahdi and Douketis, James},
title = {New Horizons in Venous Thromboembolism Management: A Narrative Review},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {21},
pages = {7668},
doi = {10.3390/jcm14217668}
}
EUVIMED